Cell-specific pattern of berberine pleiotropic effects on different human cell lines

Area of Science:

• Pharmacology
• Molecular Biology
• Cancer Research

Background:

• Berberine, a natural alkaloid, possesses diverse pharmacological activities.
• Emerging evidence suggests berberine's potential as an anticancer agent.
• Understanding its molecular mechanisms is crucial for therapeutic development.

Purpose of the Study:

• To investigate the molecular mechanisms of berberine's anti-tumor effects.
• To compare berberine's impact on glioblastoma, pancreatic carcinoma, and non-cancerous cells.
• To elucidate cell-specific responses to berberine treatment.

Main Methods:

• Cell viability assays on U343 (glioblastoma), MIA PaCa-2 (pancreatic carcinoma), and HDF (fibroblast) cells.
• Analysis of cell cycle progression, senescence, caspase-3 activity, autophagy, and migration.
• Assessment of mitochondrial dysfunction via citrate synthase activity.
• Gene expression profiling to identify modulated tumorigenesis pathways.

Main Results:

• Berberine demonstrated higher cytotoxicity against cancer cells compared to HDF.
• Differential effects on cell cycle (G1/G2 arrest), senescence, autophagy, and migration were observed across cell lines.
• Mitochondrial dysfunction was evident in all cell types following berberine exposure.
• Berberine modulated gene expression profiles related to tumorigenesis in a cell-specific manner.

Conclusions:

• Berberine exhibits differential anti-tumor effects and molecular mechanisms depending on the cell type.
• Its impact on cancer cells involves cell cycle arrest, senescence, autophagy modulation, and impaired migration.
• Mitochondrial dysfunction is a common effect, suggesting a broad cellular stress response.
• These findings highlight berberine's complex interactions with specific cell types, offering insights for targeted cancer therapy.